PGY2 Oncology Pharmacy Residency
Purpose of the Residency Program (effective July 2023)
PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.
This specialty residency program will provide advanced training for pharmacists in the fields of oncology, hematology, and blood and marrow transplantation. The resident will have the opportunity to work as an integral member within a multidisciplinary team to actively provide optimal pharmaceutical care for these complex patient populations. In addition, residents will participate in developing and supporting quality improvement initiatives, contribute to research efforts in the field, precept PGY1 pharmacy residents and pharmacy students, conduct self-assessment for professional development, and commit to continuous self-learning. The various components of this residency program shall be continuously evaluated to ensure the quality of each experience. As institutional and/or organizational dynamics change, revisions and modifications of the program may be necessary to fulfill the original established program goals.
Residency Program Director
Residency Program Coordinator